| Attributes | Values |
|---|
| rdf:type
| |
| Description
| - U 122 nemocných s NHL po autologní transplantaci periferních krvetvorných buněk byla provedena retrospektivní univariační a multivariační analýza prognostických faktorů s ohledem na celkové přežití a přežití bez návratu onemocnění. Coxovou multivariační regresní analýzou byla potvrzena prognostická hodnota hladiny LDH před transplantací pro přežití bez návratu onemocnění a hladiny LDH a beta-2-mikroglobulinu před transplantací pro celkové přežití nemocných. Byla tak potvrzena vhodnost vyšetření těchto sérových markerů před provedením transplantace u nemocných s NHL. Supported by grant MSM 6198959205. (cs)
- Several prognostic factors had been previously reported to be associated with overall and progression-free survival of patients with NHL after APSCT. We present a retrospective single center analysis with special attention to the markers that reflect the activity of disease at the time of transplantation. 122 patients with NHL indicated for APSCT for high-risk features at diagnosis partial response to first line treatment and/or relapse were included in the study. There were 66 women and 56 men at median age 45.5 years (range 19-66). 47 patients were with diagnosis of diffuse-large cell lymphoma, 34 with follicular lymphoma, 15 with mantle cell lymphoma and 26 patients had other lymphoma subtypes. Patients were transplanted in years 1997-2004. In all cases BEAM was used for conditioning. Median follow-up of patients was 27.0 months (range 3.0-93.9). 50 (41.0%) patients relapsed and 35 (28.7%) died. Age, stage of disease, IPI, bone marrow and extra-nodal involvement, presence of B symptoms and bulky di
- Several prognostic factors had been previously reported to be associated with overall and progression-free survival of patients with NHL after APSCT. We present a retrospective single center analysis with special attention to the markers that reflect the activity of disease at the time of transplantation. 122 patients with NHL indicated for APSCT for high-risk features at diagnosis partial response to first line treatment and/or relapse were included in the study. There were 66 women and 56 men at median age 45.5 years (range 19-66). 47 patients were with diagnosis of diffuse-large cell lymphoma, 34 with follicular lymphoma, 15 with mantle cell lymphoma and 26 patients had other lymphoma subtypes. Patients were transplanted in years 1997-2004. In all cases BEAM was used for conditioning. Median follow-up of patients was 27.0 months (range 3.0-93.9). 50 (41.0%) patients relapsed and 35 (28.7%) died. Age, stage of disease, IPI, bone marrow and extra-nodal involvement, presence of B symptoms and bulky di (en)
|
| Title
| - Prognostic Factors for Survival of Patients with Non-Hondgkin´s Lymphoma (NHL) after Autologous Peripheral Stem Cell Transplantation (APSCT) - Signle Center Experience
- Prognostické faktory pro přežití pacientů s nehodgkinskými lymphomy (NHL) po autologní transplantaci krvetvorných buněk - nezávislá zkušenost centra (cs)
- Prognostic Factors for Survival of Patients with Non-Hondgkin´s Lymphoma (NHL) after Autologous Peripheral Stem Cell Transplantation (APSCT) - Signle Center Experience (en)
|
| skos:prefLabel
| - Prognostic Factors for Survival of Patients with Non-Hondgkin´s Lymphoma (NHL) after Autologous Peripheral Stem Cell Transplantation (APSCT) - Signle Center Experience
- Prognostické faktory pro přežití pacientů s nehodgkinskými lymphomy (NHL) po autologní transplantaci krvetvorných buněk - nezávislá zkušenost centra (cs)
- Prognostic Factors for Survival of Patients with Non-Hondgkin´s Lymphoma (NHL) after Autologous Peripheral Stem Cell Transplantation (APSCT) - Signle Center Experience (en)
|
| skos:notation
| - RIV/61989592:15110/06:00002731!RIV07-MSM-15110___
|
| http://linked.open.../vavai/riv/strany
| |
| http://linked.open...avai/riv/aktivita
| |
| http://linked.open...avai/riv/aktivity
| |
| http://linked.open...iv/cisloPeriodika
| |
| http://linked.open...vai/riv/dodaniDat
| |
| http://linked.open...aciTvurceVysledku
| |
| http://linked.open.../riv/druhVysledku
| |
| http://linked.open...iv/duvernostUdaju
| |
| http://linked.open...titaPredkladatele
| |
| http://linked.open...dnocenehoVysledku
| |
| http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/06:00002731
|
| http://linked.open...riv/jazykVysledku
| |
| http://linked.open.../riv/klicovaSlova
| - Non-Hodgkin´s lymphoma; autologous peripheral stem cell transplantation (en)
|
| http://linked.open.../riv/klicoveSlovo
| |
| http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
| http://linked.open...ontrolniKodProRIV
| |
| http://linked.open...i/riv/nazevZdroje
| - Biology of Blood and Marrow Transplantation
|
| http://linked.open...in/vavai/riv/obor
| |
| http://linked.open...ichTvurcuVysledku
| |
| http://linked.open...cetTvurcuVysledku
| |
| http://linked.open...UplatneniVysledku
| |
| http://linked.open...v/svazekPeriodika
| |
| http://linked.open...iv/tvurceVysledku
| - Faber, Edgar
- Indrák, Karel
- Raida, Luděk
- Skoumalová, Ivana
- Vondráková, Jana
- Papajík, Tomáš
- Zapletalová, J.
- Marešová, Ivana
|
| http://linked.open...n/vavai/riv/zamer
| |
| issn
| |
| number of pages
| |
| http://localhost/t...ganizacniJednotka
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)